COMMUNITY HEALTH SYSTEMS INC (CYH)
US2036681086 - Common Stock
Taking everything into account, CYH scores 3 out of 10 in our fundamental rating. CYH was compared to 113 industry peers in the Health Care Providers & Services industry. While CYH is still in line with the averages on profitability rating, there are concerns on its financial health. CYH is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CYH has reported negative net income.
In the past year CYH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CYH reported negative net income in multiple years.
CYH had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of CYH (-2.86%) is comparable to the rest of the industry.
CYH's Return On Invested Capital of 5.41% is fine compared to the rest of the industry. CYH outperforms 64.60% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CYH is below the industry average of 8.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.86% | ||
| ROE | N/A | ||
| ROIC | 5.41% |
ROA(3y)0.3%
ROA(5y)-0.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6%
ROIC(5y)5.36%
1.3 Margins
CYH has a better Operating Margin (6.43%) than 71.68% of its industry peers.
CYH's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 84.60%, CYH belongs to the best of the industry, outperforming 96.46% of the companies in the same industry.
In the last couple of years the Gross Margin of CYH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.43% | ||
| PM (TTM) | N/A | ||
| GM | 84.6% |
OM growth 3Y12.48%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
CYH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CYH has more shares outstanding
Compared to 5 years ago, CYH has more shares outstanding
CYH has about the same debt/assets ratio as last year.
2.2 Solvency
CYH has an Altman-Z score of 0.80. This is a bad value and indicates that CYH is not financially healthy and even has some risk of bankruptcy.
CYH's Altman-Z score of 0.80 is on the low side compared to the rest of the industry. CYH is outperformed by 61.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.8 |
ROIC/WACC0.91
WACC5.92%
2.3 Liquidity
CYH has a Current Ratio of 1.46. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
CYH has a Current ratio (1.46) which is in line with its industry peers.
A Quick Ratio of 1.32 indicates that CYH should not have too much problems paying its short term obligations.
CYH has a Quick ratio (1.32) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.46 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
CYH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -296.15%.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 0.81% in the last year.
Measured over the past years, CYH shows a decrease in Revenue. The Revenue has been decreasing by -2.47% on average per year.
EPS 1Y (TTM)-296.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y1.94%
Revenue growth 5Y-2.47%
Sales Q2Q%0.13%
3.2 Future
Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 33.16% on average per year.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 1.98% on average per year.
EPS Next Y61.93%
EPS Next 2Y50.16%
EPS Next 3Y33.16%
EPS Next 5YN/A
Revenue Next Year0.4%
Revenue Next 2Y0.94%
Revenue Next 3Y1.98%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 10.30, the valuation of CYH can be described as reasonable.
Based on the Price/Forward Earnings ratio, CYH is valued cheaply inside the industry as 89.38% of the companies are valued more expensively.
CYH is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.00, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.3 |
4.2 Price Multiples
CYH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CYH is cheaper than 79.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.32 |
4.3 Compensation for Growth
CYH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CYH's earnings are expected to grow with 33.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.16%
EPS Next 3Y33.16%
5. Dividend
5.1 Amount
CYH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COMMUNITY HEALTH SYSTEMS INC
NYSE:CYH (11/22/2024, 8:04:00 PM)
After market: 3.53 -0.12 (-3.29%)3.65
-0.1 (-2.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap507.17M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.3 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.86% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 6.43% | ||
| PM (TTM) | N/A | ||
| GM | 84.6% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.46 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-296.15%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y61.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.81%
Revenue growth 3Y1.94%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y